Skip to Content

Tag: Fisher & Paykel Healthcare


News

In brief: F&P’s expectations, insulin affordability, Power 500 list

January 27, 2023HME News Staff

AUCKLAND, New Zealand – Fisher & Paykel Healthcare expects full year operating revenue for the 2023 financial year to be within the range of about $1.55 billion to $1.6 billion, the company announced on Jan. 19.  In F&P’s Homecare Product Group, sales of obstructive sleep apnea masks have remained strong, said Lewis Gradon, managing director and CEO.  “Our mask sales growth rate is currently tracking above that of our first half as global supply of CPAP hardware...

AdaptHealth, CPAP, Dr. Rory Cooper, Fisher & Paykel Healthcare, Home Medical Equipment, Insulin, ResMed, U.S. Rehab


Read Full Articlered right arrow icon

Lewis Gradon

Vendors

F&P: Mask sales have remained strong

January 23, 2023HME News Staff

AUCKLAND, New Zealand – Fisher & Paykel Healthcare expects full year operating revenue for the 2023 financial year to be within the range of about $1.55 billion to $1.6 billion, the company announced on Jan. 19.  In F&P’s Homecare Product Group, sales of obstructive sleep apnea masks have remained strong, said Lewis Gradon, managing director and CEO.  “Our mask sales growth rate is currently tracking above that of our first half as global supply of CPAP hardware...

CPAP, Fisher & Paykel Healthcare


Read Full Articlered right arrow icon

Lewis Gradon

Vendors

F&P sees ‘a lot of drivers’ for growth in home care

December 2, 2022Liz Beaulieu, Editor

AUCKLAND, New Zealand – Fisher & Paykel Healthcare’s Homecare Product Group was a bright spot in the company’s financial results for the first half of the 2023 financial year, with revenue up 10% over the prior comparable period.  Revenue for OSA masks and accessories, specifically, increased 16% on the back of the positive reception to F&P’s new Evora Full. The mask, which features a floating seal and stability wings, received 510(k) clearance from the U.S. Food and...

CPAP, Fisher & Paykel Healthcare


Read Full Articlered right arrow icon

Vendors

F&P Healthcare reports double-digit decreases

November 29, 2022HME News Staff

AUCKLAND, New Zealand – Fisher & Paykel Healthcare reported a 23% decline in operating revenue to $690.6 million for the first half of the 2023 financial year. The company pointed out, however, that this was more than the $670 million guided in an August trading update and a 21% increase on the comparable pre-pandemic period.   “Consistent with what we signaled in August, first half revenue was down on the prior corresponding period, as we lapped significant COVID-19-driven...

Financial Results, Fisher & Paykel Healthcare


Read Full Articlered right arrow icon

Also Noted

F&P looks to build second campus

September 1, 2022HME News Staff

AUCKLAND, New Zealand – Fisher & Paykel Healthcare has entered into a sale and purchase agreement to acquire a 105-hectare site in Karaka for $275 million to build a second campus in New Zealand. “With our current site nearing capacity, we are pleased to take this step towards securing additional land to enable our continued growth,” said Scott St. John, board chair for Fisher & Paykel Healthcare. “We have consistently signaled the importance of long-term infrastructure planning...

Fisher & Paykel Healthcare


Read Full Articlered right arrow icon

News

In brief: FDA update, F&P prediction, home infusion access

August 26, 2022HME News Staff

WASHINGTON – The U.S. Food and Drug Administration updated its safety communication for the Philips recall this month, saying it received more than 48,000 medical device reports, including 44 reports of death, associated with the foam breakdown or suspected foam breakdown in certain CPAP devices from May 1, 2022, through July 31, 2022.  The agency previously reported in May that it received more than 21,000 MDRs, including 124 reports of death, associated with the foam breakdown...

Fisher & Paykel Healthcare, Home Infusion Therapy, Philips Recall


Read Full Articlered right arrow icon

F&P predicts revenue boost in second half 

Vendors

F&P predicts revenue boost in second half 

August 22, 2022HME News Staff

AUCKLAND, N.Z. – Fisher & Paykel Healthcare expects operating revenue for the first half of the 2023 financial year to be about $670 million and net profit after tax to be about $85 million to $95 million, assuming current exchange rates and a continuation of trading conditions in the first four months.  This would represent an increase in revenue on pre-pandemic levels ($570.9 million in the first half of fiscal year 2020) and a decline in revenue compared to the prior comparable period...

Financial Results, Fisher & Paykel Healthcare


Read Full Articlered right arrow icon

Also Noted

Fisher & Paykel board director to retire

July 6, 2022HME News Staff

AUCKLAND, New Zealand – Fisher & Paykel Healthcare Director Geraldine McBride will retire from the board at the close of the company’s annual shareholders meeting in August. She has served as an independent director on the board since August 2013. “Geraldine has been a valuable presence in the boardroom throughout a period of significant growth for our company,” said Scott St John, board chair. “We have benefited greatly from her experience, drawn from a successful career...

Fisher & Paykel Healthcare


Read Full Articlered right arrow icon

Also Noted

F&P selects Future Director 

May 31, 2022HME News Staff

AUCKLAND, New Zealand – Fisher & Paykel Healthcare has selected Tracey Barron to participate in the Future Directors program starting June 1. Barron has more than 25 years of experience across a broad range of health-related roles, including chief of strategy for Southern Cross Healthcare. “We welcome the perspective and experience Tracey will bring,” said Scott St. John, chairman of the board. “She is a proven executive with a deep understanding of public and private health...

Fisher & Paykel Healthcare, Future Directors


Read Full Articlered right arrow icon

Also Noted

F&P adds professor to board 

May 31, 2022HME News Staff

AUCKLAND, New Zealand – Cather Simpson, a PhD with expertise in lasers and photonics, has been appointed as a non-executive director of Fisher & Paykel Healthcare starting June 1. Simpson is a professor of physics and chemical sciences at the University of Auckland and a partner at Pacific Channel, an early-stage investment company. She is also a director of the International Society for Optics & Photonics (SPIE) and founder/director for Orbis Diagnostics. “We are pleased to announce...

Board of Directors, Cather Simpson, Fisher & Paykel Healthcare


Read Full Articlered right arrow icon